PuSH - Publication Server of Helmholtz Zentrum München: Association of cardiometabolic multimorbidity with mortality.

Information

Clues to quality of journals

Open Access Policy of Helmholtz Association 2016

CC Licencences

Publication Metrics

Navigation

Home

Deutsch

EVA: Electronic Publishing

New EVA Application

Research

Advanced Search

Browse by ...

... HMGU-Authors/Consortia

... Organizational Structure

... Journal

... Publication Type

... Research Data

... Arbeitsgruppen

... Publication Year

Publication overview

Statistics

Statistics (last 5 years)

OA Publications

Publish

Submit Publication

Import publication from...

...EVA

Report missing publication

Highlights

Support & Contact

Contact persons

Help

Data protection

Helmholtz Open Science

JANE Journal Estimator

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Emerging Risk Factors Collaboration (di Angelantonio, E.* ; Kaptoge, S.* ; Wormser, D.* ; Willeit, P.* ; Butterworth, A.S.* ; Bansal, N.* ; O'Keeffe, L.M.* ; Gao, P.* ; Wood, A.M.* ; Burgess, S.L.* ; Freitag, D.F.* ; Pennells, L.* ; Peters, S.A.* ; Hart, C.L.* ; Håheim, L.L.* ; Gillum, R.F.* ; Nørdestgaard, B.G.* ; Psaty, B.M.* ; Yeap, B.B.* ; Knuiman, M.W.* ; Nietert, P.J.* ; Kauhanen, J.* ; Salonen, J.T.* ; Kuller, L.H.* ; Simons, L.A.* ; van der Schouw, Y.T.* ; Barrett-Connor, E.* ; Selmer, R.* ; Crespo, C.J.* ; Rodriguez, B.* ; Verschuren, W.M.* ; Salomaa, V.* ; Svärdsudd, K.* ; van der Harst, P.* ; Björkelund, C.* ; Wilhelmsen, L.* ; Wallace, R.B.* ; Brenner, H.* ; Amouyel, P.* ; Barr, E.L.* ; Iso, H.* ; Onat, A.* ; Trevisan, M.* ; D'Agostino, R.B.* ; Cooper, C.* ; Kavousi, M.* ; Welin, L.* ; Roussel, R.* ; Hu, F.B.* ; Sato, S.* ; Davidson, K.W.* ; Howard, B.V.* ; Leening, M.* ; Rosengren, A.* ; Dörr, M.* ; Deeg, D.J.* ; Kiechl, S.* ; Stehouwer, C.D.* ; Nissinen, A.* ; Giampaoli, S.* ; Donfrancesco, C.* ; Kromhout, D.* ; Price, J.F.* ; Peters, A. ; Meade, T.W.* ; Casiglia, E.* ; Lawlor, D.A.* ; Gallacher, J.* ; Nagel, D.* ; Franco, O.H.* ; Assmann, G.* ; Dagenais, G.R.* ; Jukema, J.W.* ; Sundström, J.* ; Woodward, M.* ; Brunner, E.J.* ; Khaw, K.T.* ; Wareham, N.J.* ; Whitsel, E.A.* ; Njølstad, I.* ; Hedblad, B.* ; Wassertheil-Smoller, S.* ; Engström, G.* ; Rosamond, W.D.* ; Selvin, E.* ; Sattar, N.* ; Thompson, S.G.* ; Danesh, J.*)

Association of cardiometabolic multimorbidity with mortality.

JAMA 314, 52-60 (2015)

Publ. Version/Full Text

DOI

PMC

	Closed

Open Access Green as soon as Postprint is submitted to ZB.

Abstract
Metrics
Extra information

Importance: The prevalence of cardiometabolic multimorbidity is increasing. Objective: To estimate reductions in life expectancy associated with cardiometabolic multimorbidity. Design, Setting, and Participants: Age- and sex-adjusted mortality rates and hazard ratios (HRs) were calculated using individual participant data from the Emerging Risk Factors Collaboration (689 300 participants; 91 cohorts; years of baseline surveys: 1960-2007; latest mortality follow-up: April 2013; 128 843 deaths). The HRs from the Emerging Risk Factors Collaboration were compared with those from the UK Biobank (499 808 participants; years of baseline surveys: 2006-2010; latest mortality follow-up: November 2013; 7995 deaths). Cumulative survival was estimated by applying calculated age-specific HRs for mortality to contemporary US age-specific death rates. Exposures: A history of 2 or more of the following: diabetes mellitus, stroke, myocardial infarction (MI). Main Outcomes and Measures: All-cause mortality and estimated reductions in life expectancy. Results: In participants in the Emerging Risk Factors Collaboration without a history of diabetes, stroke, or MI at baseline (reference group), the all-cause mortality rate adjusted to the age of 60 years was 6.8 per 1000 person-years. Mortality rates per 1000 person-years were 15.6 in participants with a history of diabetes, 16.1 in those with stroke, 16.8 in those with MI, 32.0 in those with both diabetes and MI, 32.5 in those with both diabetes and stroke, 32.8 in those with both stroke and MI, and 59.5 in those with diabetes, stroke, and MI. Compared with the reference group, the HRs for all-cause mortality were 1.9 (95% CI, 1.8-2.0) in participants with a history of diabetes, 2.1 (95% CI, 2.0-2.2) in those with stroke, 2.0 (95% CI, 1.9-2.2) in those with MI, 3.7 (95% CI, 3.3-4.1) in those with both diabetes and MI, 3.8 (95% CI, 3.5-4.2) in those with both diabetes and stroke, 3.5 (95% CI, 3.1-4.0) in those with both stroke and MI, and 6.9 (95% CI, 5.7-8.3) in those with diabetes, stroke, and MI. The HRs from the Emerging Risk Factors Collaboration were similar to those from the more recently recruited UK Biobank. The HRs were little changed after further adjustment for markers of established intermediate pathways (eg, levels of lipids and blood pressure) and lifestyle factors (eg, smoking, diet). At the age of 60 years, a history of any 2 of these conditions was associated with 12 years of reduced life expectancy and a history of all 3 of these conditions was associated with 15 years of reduced life expectancy. Conclusions and Relevance: Mortality associated with a history of diabetes, stroke, or MI was similar for each condition. Because any combination of these conditions was associated with multiplicative mortality risk, life expectancy was substantially lower in people with multimorbidity.

Impact Factor

Scopus SNIP

Web of Science
Times Cited

Scopus
Cited By

Altmetric

35.289

8.859

328

325